|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 P$ f( r7 X2 o2 q8 M5 J: m7 @! t* `( ^
- @$ I( w* `/ |! W8 J今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
8 f: e; e- {4 m! p6 J4 O" a& @2 [( A' t* p
头颈肿瘤BU入选ASCO 2025的研究. ^# `1 ?- A8 M; A/ w
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
6 R3 o9 \' f6 `6 M& O/ z. A肿瘤内科-头颈肿瘤科姜愚团队0 h! a; H$ p4 v* q
+ c$ {1 p3 o- ~Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.6 [" j8 g; T: q; A8 R
肿瘤内科-头颈肿瘤科刘磊团队
( N. {. W) N/ p x) l- Q$ G0 m2 O6 _
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.% j. \' G- W# S/ a# z3 N2 E
肿瘤内科-头颈肿瘤科刘磊团队
! i$ F% O& h. B4 \0 K0 F* O" Z1 F! r3 j, w# Z) W; ?
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.' Y4 Y. h, r$ k A
肿瘤内科-头颈肿瘤科刘磊团队
( S, ?- p" W3 M9 x
1 w2 g+ w* k4 B4 r* I0 a2 c/ {ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
; ?: i! [3 Q, `: {) T! c& M肿瘤内科-头颈肿瘤科姜愚团队- ^$ r( M( E0 d5 e+ f, s
|
|
[复制链接]
发表于 2025-5-9 16:51:15
